Amoéba : Deferral of the 5th tranche of OCAs
Amoéba announces the deferral of the issuance of the 5th tranche of bonds convertible into shares.
Chassieu (France), April 5, 2022 – 5:45 p.m. – AMOÉBA (FR0011051598 – ALMIB), producer of a
biological biocide capable of eliminating bacterial risk in water and human wounds, and of a
biocontrol product for plant protection, still in the development phase, informs that it has exercised
the suspension option relating to the issue of the 5th tranche of OCAs.
In accordance with article 3.1.3 of the contract for the issuance of bonds convertible into shares
signed with Nice & Green SA on December 17, 2020, Amoéba has decided to exercise the
suspension option relating to the issuance of the 5th tranche of 60 bonds, initially scheduled on
April 5 2022. According to the terms of the contract, this suspension can be exercised for a maximum
period of 2 months. The exercise of the suspension option results in the automatic postponement of
the issuance of the suspended tranche immediately after the suspension period and the commitment
period is extended for a maximum period equal to the suspension phase.